NEW YORK (GenomeWeb News) – Stratos Product Development said today it is partnering with nanoMR to develop an instrument to rapidly isolate multiple cell types and more rapidly detect pathogens.

The instrument will be built on nanoMR's Pathogen Capture System, and will allow clinicians to begin appropriate antibiotic treatment sooner, leading to better patient outcomes, Seattle-based Stratos said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.